ESSA Pharma (EPIX) Stock Chart & Stock Price History $1.83 +0.07 (+3.98%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ESSA Pharma Stock Price Performance 5 Day Performance+5.17%1 Month Performance-69.35%3 Month Performance-64.88%6 Month Performance-71.36%Year-To-Date Performance-72.27%1 Year Performance-68.12% Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Coins Set to Soar with a Pro-Crypto White House (Ad)Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…Click here to reserve your free seat at the Crypto Community Summit EPIX Stock Chart for Sunday, November, 24, 2024 EPIX Chart by TradingView ESSA Pharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$1.77$1.83+3.39%$1.85$1.73360,728 shs$81.20 million11/21/2024$1.73$1.77+2.31%$1.82$1.74232,553 shs$78.54 million11/20/2024$1.74$1.73-0.57%$1.78$1.69196,493 shs$76.76 million11/19/2024$1.71$1.74+1.75%$1.76$1.67241,950 shs$77.20 million11/18/2024$1.72$1.71-0.58%$1.75$1.66385,614 shs$75.87 million11/15/2024$1.76$1.72-2.27%$1.83$1.69781,828 shs$76.32 million Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$1.77$1.76-0.56%$1.86$1.75449,996 shs$78.09 million11/13/2024$1.86$1.77-4.84%$1.88$1.77425,985 shs$78.53 million11/12/2024$1.79$1.86+3.91%$1.89$1.79527,817 shs$82.53 million11/11/2024$1.80$1.79-0.56%$1.88$1.75606,140 shs$79.42 million11/08/2024$1.77$1.80+1.69%$1.88$1.76868,119 shs$79.87 million11/07/2024$1.71$1.77+3.51%$1.89$1.701.33 million shs$78.54 million11/06/2024$1.70$1.71+0.59%$1.77$1.66923,485 shs$75.87 million11/05/2024$1.63$1.70+4.29%$1.79$1.601.71 million shs$75.43 million11/04/2024$1.40$1.63+16.43%$1.69$1.545.97 million shs$72.32 million11/01/2024$5.20$1.40-73.08%$1.60$1.4034.23 million shs$62.12 million10/31/2024$5.28$5.20-1.52%$5.38$5.0127,568 shs$230.69 million10/30/2024$5.41$5.28-2.40%$5.57$5.1121,075 shs$234.24 million10/29/2024$5.49$5.41-1.46%$5.75$5.4122,474 shs$240.00 million10/28/2024$5.55$5.49-1.08%$5.76$5.4714,677 shs$243.55 million10/25/2024$5.97$5.55-7.04%$5.96$5.5022,671 shs$246.22 million10/24/2024$5.37$5.97+11.17%$5.97$5.3593,633 shs$264.85 million10/23/2024$5.74$5.37-6.45%$5.75$5.0089,307 shs$238.23 million Related Companies Kodiak Sciences Stock Price Chart Aclaris Therapeutics Stock Price Chart COMPASS Pathways Stock Price Chart iTeos Therapeutics Stock Price Chart Sage Therapeutics Stock Price Chart Voyager Therapeutics Stock Price Chart ProQR Therapeutics Stock Price Chart uniQure Stock Price Chart C4 Therapeutics Stock Price Chart Rezolute Stock Price Chart Receive EPIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPIX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
